Big Pharma’s Lobbying Campaign to Keep on Price-Gouging | The Influence

There are efforts to stop the apparent pharmaceutical industry profiteering and opportunism like pending state bills to force drug makers to reveal their true costs and allow insurers to refuse payment. The White House is also launching a new Medicare payment system to stop the incentives for a doctor to use a $2,000 drug when a $50 drug would do.

Now Pharma is fighting back. Its lobbying groups have launched a Washington, DC-focused campaign to keep lawmakers from legislating away its profit party.
Read more>>

Comments